Coherent Market Insights has released a new research study on the "Radiopharmaceuticals in Nuclear Medicine Market" which aims to provide a thorough examination of the factors influencing global business introduction and outlook. The Global Radiopharmaceuticals in Nuclear Medicine Market Report detailed information and overview highlight the most recent trends in various regions. Leading market participants will benefit from the trading insights provided in this report.
Therapeutic applications of radiopharmaceuticals include treatment of specific cancers under specific conditions. For instance, Yttrium-90 Ibritumomab Tiuxetan (Zevalin, Spectrum Pharmaceuticals) is indicated for the treatment of relapsed or refractory, low-grade or follicular B-cell non-Hodgkin’s lymphoma (NHL) and treatment of previously untreated follicular NHL in patients who achieve a partial or complete response to first-line chemotherapy.
The global radiopharmaceuticals in nuclear medicine market is estimated to be valued at US$ 6,700.5 million in 2020 and is expected to exhibit a CAGR of 8.0% over the forecast period (2020-2027).
Request Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/70
Market Dynamics
Market players are focusing on various inorganic growth strategies such as collaboration and partnership agreements in order to expand their market presence, which is expected to boost growth of the global radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, in October 2018, Cardinal Health Inc. and Telix Pharmaceuticals Inc., a subsidiary of Telix Pharmaceuticals Limited, entered into a distribution agreement.
Key features of the study:
This report provides in-depth analysis of the global radiopharmaceuticals in nuclear medicine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
Request PDF Brochure Of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/70
Detailed Segmentation:
Global Radiopharmaceuticals in Nuclear Medicine Market, By Product Type:
Diagnostic Nuclear Medicine
SPECT Radiopharmaceuticals
PET Radiopharmaceuticals
Therapeutic Nuclear Medicine
Global Radiopharmaceuticals in Nuclear Medicine Market, By Application:
Oncology
Cardiology
Neurology
Endocrinology
Others
Global Radiopharmaceuticals in Nuclear Medicine Market, By End User:
Hospitals
Specialty Clinics
Diagnostic Centers
Browse Complete Report For More Information @ https://www.coherentmarketinsights.com/insight/buy-now/70
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com
